ArticleSAGE open medical case reports2026
Multiple eruptive dermatofibromas occurring in association with monoclonal gammopathy of undetermined significance: A case report.
Article in SAGE open medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple eruptive dermatofibroma is a rare variant of dermatofibroma and often occurs in association with systemic disease, particularly involving immune dysregulation. We present what may be the first reported case of multiple eruptive dermatofibroma in association with monoclonal gammopathy of undetermined significance, a premalignant plasma cell dyscrasia. A 66-year-old male with stable IgM monoclonal gammopathy of undetermined significance developed over 50 asymptomatic papulonodular lesions over two years. Histopathology confirmed dermatofibromas, the timeline of lesion development was consistent with multiple eruptive dermatofibroma, and laboratory evaluation revealed elevated IgM and a monoclonal paraprotein band. This case highlights a novel systemic association between multiple eruptive dermatofibroma and monoclonal gammopathy of undetermined significance. Given the frequent co-occurrence of immune dysregulation in patients with multiple eruptive dermatofibroma, evaluation for underlying systemic immunologic conditions in affected individuals is warranted. Recognition of such associations may facilitate earlier diagnosis and surveillance of systemic disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.